HAB Pharmaceuticals and Research Ltd. (HAB), a leading pharma company in India, has partnered with Jai Vakeel Autism Centre (JVAC) towards the foundation’s efforts in providing education, skills and healthcare to children diagnosed with Autism Spectrum Disorder (ASD).
 |
HAB Pharma and JVAC: Building an Inclusive Society for Autism in India
A study conducted by the Indian Council of Medical Research (ICMR) in collaboration with the Ministry of Health and Family Welfare, Government of India, which was published in the Indian Journal of Pediatrics in 2018, surveyed over 200,000 children aged between 2 and 9 years from all over India and found that the prevalence of autism was 1 in 68.
According to recent statistics, there are around 18 million people living with autism in India, making it one of the largest autistic populations in the world. Despite this, many families in India still struggle to access appropriate care and resources for their loved ones with autism, highlighting the need for increased awareness and support for individuals with ASD in the country.
Through this collaboration, HAB wishes to strengthen the integration of autistic children and adults into society. The funds are mainly used for therapies that focus on language, social interaction and sensory needs.
“A truly fulfilled society is an inclusive society. This means we strive to create potentially independent adults that can become contributing members of the community,” says Urvee Garg, their Business Operations Manager.
